monocrotaline has been researched along with Liver Dysfunction in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Agulham, AP; Bertoldi, AS; Gewehr, DM; Giovanini, AF; Kubrusly, FB; Kubrusly, LF; Mattar, BA; Nagashima, S | 1 |
| Hanawa, H; Hayashi, Y; Jiao, S; Kashimura, T; Minamino, T; Obata, H; Ohno, Y; Suzuki, T; Tanaka, K; Watanabe, T; Yoshida, K | 1 |
| Bethea, NW; DeLeve, LD; Ito, Y; McCuskey, MK; McCuskey, RS; Wang, X | 1 |
| HILL, KR | 1 |
| Bae, SH; Jung, Y; Oh, SH; Petersen, BE; Piscaglia, AC; Witek, RP; Zheng, D | 1 |
| Dhawan, BN; Dwivedi, Y; Garg, NK; Mehrotra, R; Rastogi, R; Sharma, SK | 1 |
| Dalvi, RR | 1 |
7 other study(ies) available for monocrotaline and Liver Dysfunction
| Article | Year |
|---|---|
Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension.
Topics: Animals; Disease Models, Animal; Hypertrophy, Right Ventricular; Liver Diseases; Male; Monocrotaline; Pulmonary Arterial Hypertension; Rats; Rats, Wistar | 2021 |
Liver congestion in heart failure contributes to inappropriately increased serum hepcidin despite anemia.
Topics: Aged; Anemia; Animals; Biomarkers; Female; Heart Failure; Hepcidins; Humans; Iron; Liver Diseases; Male; Middle Aged; Monocrotaline; Organ Size; Oxygen; Prevalence; Rats, Inbred Lew | 2015 |
Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome.
Topics: Animals; Cell Size; Disease Models, Animal; Endothelium; Erythrocytes; Glutathione; Liver Diseases; Male; Microcirculation; Monocrotaline; Perfusion; Phagocytosis; Rats; Rats, Sprague-Dawley; Syndrome | 2003 |
Hepatic veno-occlusive disease produced experimentally in rats by the injection of monocrotaline.
Topics: Alkaloids; Animals; Disease; Hepatic Veins; Hepatic Veno-Occlusive Disease; Injections; Liver Diseases; Monocrotaline; Rats | 1958 |
Bone marrow-derived hepatic oval cells differentiate into hepatocytes in 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration.
Topics: 2-Acetylaminofluorene; alpha-Fetoproteins; Animals; Animals, Genetically Modified; Antimitotic Agents; Bone Marrow Cells; Bone Marrow Transplantation; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chemical and Drug Induced Liver Injury; Dipeptidyl Peptidase 4; Disease Models, Animal; Female; Hepatectomy; Hepatocytes; Liver; Liver Diseases; Liver Regeneration; Male; Monocrotaline; Rats; Rats, Inbred F344; Stem Cells; Time Factors; X Chromosome; Y Chromosome | 2007 |
Picroliv protects against monocrotaline-induced hepatic damage in rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cinnamates; Glycosides; Liver Diseases; Male; Monocrotaline; Plant Extracts; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Vanillic Acid | 1991 |
Dose-related inhibition of the drug-metabolizing enzymes of rat liver by the pyrrolizidine alkaloid, monocrotaline.
Topics: Animals; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Liver Diseases; Male; Microsomes, Liver; Monocrotaline; Oxidoreductases; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Transaminases | 1987 |